vs
Side-by-side financial comparison of Bath & Body Works, Inc. (BBWI) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
Bath & Body Works, Inc. is the larger business by last-quarter revenue ($1.6B vs $1.1B, roughly 1.4× PERRIGO Co plc). Bath & Body Works, Inc. runs the higher net margin — 4.8% vs -127.8%, a 132.6% gap on every dollar of revenue. On growth, Bath & Body Works, Inc. posted the faster year-over-year revenue change (-1.0% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $-1.0M). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -26.0%).
Bath & Body Works, Inc. is an American specialty retail company based in Columbus, Ohio. It owns Bath & Body Works, posted $7.4 billion in revenue in 2023, and was listed as 481 on the 2024 Fortune 500 list of largest United States companies by revenue.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
BBWI vs PRGO — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.6B | $1.1B |
| Net Profit | $77.0M | $-1.4B |
| Gross Margin | 41.3% | 32.6% |
| Operating Margin | 10.1% | -116.0% |
| Net Margin | 4.8% | -127.8% |
| Revenue YoY | -1.0% | -2.5% |
| Net Profit YoY | -27.4% | -3093.9% |
| EPS (diluted) | $0.37 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.6B | $1.1B | ||
| Q3 25 | $1.5B | $1.0B | ||
| Q2 25 | $1.4B | $1.1B | ||
| Q1 25 | $2.8B | $1.0B | ||
| Q4 24 | $1.6B | $1.1B | ||
| Q3 24 | $1.5B | $1.1B | ||
| Q2 24 | $1.4B | $1.1B | ||
| Q1 24 | $2.9B | $1.1B |
| Q4 25 | $77.0M | $-1.4B | ||
| Q3 25 | $64.0M | $7.5M | ||
| Q2 25 | $105.0M | $-8.4M | ||
| Q1 25 | $453.0M | $-6.4M | ||
| Q4 24 | $106.0M | $-44.4M | ||
| Q3 24 | $152.0M | $-21.0M | ||
| Q2 24 | $87.0M | $-108.4M | ||
| Q1 24 | $579.0M | $2.0M |
| Q4 25 | 41.3% | 32.6% | ||
| Q3 25 | 41.3% | 36.1% | ||
| Q2 25 | 45.4% | 34.4% | ||
| Q1 25 | 46.7% | 37.6% | ||
| Q4 24 | 43.5% | 33.9% | ||
| Q3 24 | 41.0% | 37.2% | ||
| Q2 24 | 43.8% | 37.0% | ||
| Q1 24 | 45.9% | 33.1% |
| Q4 25 | 10.1% | -116.0% | ||
| Q3 25 | 10.1% | 7.0% | ||
| Q2 25 | 14.7% | 4.3% | ||
| Q1 25 | 24.3% | 4.5% | ||
| Q4 24 | 13.5% | 10.0% | ||
| Q3 24 | 12.0% | 7.4% | ||
| Q2 24 | 13.5% | -2.5% | ||
| Q1 24 | 23.9% | -5.1% |
| Q4 25 | 4.8% | -127.8% | ||
| Q3 25 | 4.1% | 0.7% | ||
| Q2 25 | 7.4% | -0.8% | ||
| Q1 25 | 16.3% | -0.6% | ||
| Q4 24 | 6.6% | -3.9% | ||
| Q3 24 | 10.0% | -1.9% | ||
| Q2 24 | 6.3% | -10.2% | ||
| Q1 24 | 19.9% | 0.2% |
| Q4 25 | $0.37 | $-10.23 | ||
| Q3 25 | $0.30 | $0.05 | ||
| Q2 25 | $0.49 | $-0.06 | ||
| Q1 25 | $2.06 | $-0.05 | ||
| Q4 24 | $0.49 | $-0.32 | ||
| Q3 24 | $0.68 | $-0.15 | ||
| Q2 24 | $0.38 | $-0.79 | ||
| Q1 24 | $2.54 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $236.0M | — |
| Total DebtLower is stronger | $3.9B | — |
| Stockholders' EquityBook value | $-1.6B | $2.9B |
| Total Assets | $5.0B | $8.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $236.0M | — | ||
| Q3 25 | $364.0M | $432.1M | ||
| Q2 25 | $636.0M | $454.2M | ||
| Q1 25 | $674.0M | $409.9M | ||
| Q4 24 | $191.0M | $558.8M | ||
| Q3 24 | $514.0M | $1.5B | ||
| Q2 24 | $855.0M | $542.8M | ||
| Q1 24 | $1.1B | $658.5M |
| Q4 25 | $3.9B | — | ||
| Q3 25 | $3.9B | — | ||
| Q2 25 | $3.9B | — | ||
| Q1 25 | $3.9B | — | ||
| Q4 24 | $4.2B | — | ||
| Q3 24 | $4.2B | — | ||
| Q2 24 | $4.3B | — | ||
| Q1 24 | $4.4B | — |
| Q4 25 | $-1.6B | $2.9B | ||
| Q3 25 | $-1.5B | $4.4B | ||
| Q2 25 | $-1.5B | $4.5B | ||
| Q1 25 | $-1.4B | $4.4B | ||
| Q4 24 | $-1.7B | $4.3B | ||
| Q3 24 | $-1.7B | $4.6B | ||
| Q2 24 | $-1.7B | $4.5B | ||
| Q1 24 | $-1.6B | $4.7B |
| Q4 25 | $5.0B | $8.5B | ||
| Q3 25 | $4.8B | $10.1B | ||
| Q2 25 | $4.9B | $10.1B | ||
| Q1 25 | $4.9B | $9.8B | ||
| Q4 24 | $5.0B | $9.6B | ||
| Q3 24 | $4.9B | $11.2B | ||
| Q2 24 | $5.2B | $10.4B | ||
| Q1 24 | $5.5B | $10.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $80.0M | $175.4M |
| Free Cash FlowOCF − Capex | $-1.0M | $148.6M |
| FCF MarginFCF / Revenue | -0.1% | 13.4% |
| Capex IntensityCapex / Revenue | 5.1% | 2.4% |
| Cash ConversionOCF / Net Profit | 1.04× | — |
| TTM Free Cash FlowTrailing 4 quarters | $946.0M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.0M | $175.4M | ||
| Q3 25 | $-43.0M | $51.7M | ||
| Q2 25 | $188.0M | $75.9M | ||
| Q1 25 | $955.0M | $-64.5M | ||
| Q4 24 | $-99.0M | $312.6M | ||
| Q3 24 | $-46.0M | $42.2M | ||
| Q2 24 | $76.0M | $9.5M | ||
| Q1 24 | $926.0M | $-1.4M |
| Q4 25 | $-1.0M | $148.6M | ||
| Q3 25 | $-99.0M | $29.8M | ||
| Q2 25 | $151.0M | $56.7M | ||
| Q1 25 | $895.0M | $-90.0M | ||
| Q4 24 | $-164.0M | $274.9M | ||
| Q3 24 | $-101.0M | $15.1M | ||
| Q2 24 | $30.0M | $-18.9M | ||
| Q1 24 | $878.0M | $-26.5M |
| Q4 25 | -0.1% | 13.4% | ||
| Q3 25 | -6.4% | 2.9% | ||
| Q2 25 | 10.6% | 5.4% | ||
| Q1 25 | 32.1% | -8.6% | ||
| Q4 24 | -10.2% | 24.2% | ||
| Q3 24 | -6.6% | 1.4% | ||
| Q2 24 | 2.2% | -1.8% | ||
| Q1 24 | 30.2% | -2.4% |
| Q4 25 | 5.1% | 2.4% | ||
| Q3 25 | 3.6% | 2.1% | ||
| Q2 25 | 2.6% | 1.8% | ||
| Q1 25 | 2.2% | 2.4% | ||
| Q4 24 | 4.0% | 3.3% | ||
| Q3 24 | 3.6% | 2.5% | ||
| Q2 24 | 3.3% | 2.7% | ||
| Q1 24 | 1.6% | 2.3% |
| Q4 25 | 1.04× | — | ||
| Q3 25 | -0.67× | 6.89× | ||
| Q2 25 | 1.79× | — | ||
| Q1 25 | 2.11× | — | ||
| Q4 24 | -0.93× | — | ||
| Q3 24 | -0.30× | — | ||
| Q2 24 | 0.87× | — | ||
| Q1 24 | 1.60× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BBWI
| Bath Body Works Stores | $1.2B | 77% |
| Bath Body Works Direct | $299.0M | 19% |
| Bath Body Works International | $73.0M | 5% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
